TGV Sraac has received an approval for making further investment of upto Rs 10 crore in Brilliant Bio Pharma (BBPL). The company intends to enter into the field of pharma in future for forward integration and value addition. By partnering with the already established BBPL will help the company to understand and make a step to focus on the pharma for future. The Board of Directors in their meeting held on May 19, 2022 has given approval to the same.
TGV Sraac (Formerly Known as Sree Rayalaseema Alkalies and Allied Chemicals) is engaged in the Business of leading producer of Chlor-Alkali products, Chloromethane and also manufactures Castor Derivatives and Fatty Acids.
